Valuation : Shanghai Pharmaceuticals Holding Co., Ltd

Market Cap 54.11B 8.07B 6.95B 6.58B 5.96B 11.19B 771B 11.25B 78.15B 30.05B 392B 30.29B 29.63B 1,239B P/E 2026 *
10.7x
P/E 2027 * 10.1x
Enterprise Value 56.82B 8.47B 7.3B 6.91B 6.26B 11.75B 809B 11.81B 82.06B 31.56B 412B 31.81B 31.11B 1,301B EV / Sales 2026 *
0.19x
EV / Sales 2027 * 0.21x
Free-Float
41.21%
Yield 2026 *
2.81%
Yield 2027 * 2.98%
1 day-1.97%
1 month-3.10%
3 months-4.74%
6 months-4.74%
Current year-12.03%
1 month 7.22
Extreme 7.22
7.38
Current year 7.04
Extreme 7.04
7.97
1 year 7.04
Extreme 7.04
8.32
3 years 5.96
Extreme 5.9575
9.44
5 years 5.96
Extreme 5.9575
10.56
10 years 5.96
Extreme 5.9575
15.14
Manager TitleAgeSince
Director of Finance/CFO 54 25/06/2026
President 56 29/06/2023
Director of Finance/CFO 53 05/06/2013
Director TitleAgeSince
Director/Board Member 53 28/06/2016
Director/Board Member 56 27/06/2019
Director/Board Member 49 29/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
-1.97%-.--% - - 8.07B
+0.07%-2.92%+22.47%+107.95% 103B
-0.61%-5.10%+53.85%+161.42% 54.56B
-0.38%-2.59%-12.33%+250.67% 21.7B
-0.12%-1.99%-10.93%-8.74% 8.07B
-1.35%-4.06%-38.62%-33.32% 6.86B
+0.59%+0.68%+3.49%+31.73% 6.82B
-0.90%-2.10%-19.20%-29.86% 6.11B
-10.00%+1.12%+354.83%+495.04% 4.6B
+0.30%+0.06%-4.49%+19.70% 5.07B
Average -1.44%-1.76%+38.78%+110.51% 24.06B
Weighted average by Cap. -0.47%-3.11%+28.36%+126.76%

Financials

2026 *2027 *
Net sales 296B 44.17B 38.06B 36.04B 32.66B 61.28B 4,220B 61.59B 428B 165B 2,147B 166B 162B 6,784B 315B 46.89B 40.4B 38.26B 34.68B 65.05B 4,480B 65.38B 454B 175B 2,279B 176B 172B 7,202B
Net income 5.64B 840M 724M 685M 621M 1.17B 80.25B 1.17B 8.14B 3.13B 40.83B 3.15B 3.09B 129B 5.8B 864M 744M 705M 639M 1.2B 82.53B 1.2B 8.37B 3.22B 41.99B 3.24B 3.17B 133B
Net Debt 2.71B 404M 348M 329M 298M 560M 38.56B 563M 3.91B 1.5B 19.62B 1.52B 1.48B 62B 12.55B 1.87B 1.61B 1.53B 1.38B 2.6B 179B 2.61B 18.13B 6.97B 90.93B 7.03B 6.87B 287B
Logo Shanghai Pharmaceuticals Holding Co., Ltd
Shanghai Pharmaceuticals Holding Co Ltd is a China-based company mainly engaged in pharmaceutical distribution business. The Company mainly operates four business segments. The Industrial segment is mainly engaged in the research and development, production, and sales of drugs and health products. The Distribution segment is mainly engaged in providing distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and distributors. The Retail segment is mainly engaged in operating and franchising the retail pharmacy network. The Others segment mainly engage in other businesses. The Company mainly operates its businesses in the domestic market.
Employees
48,640
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
16.29CNY
Average target price
20.80CNY
Spread / Average Target
+27.67%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!